Understanding Your Heart Valves and Disease Stages
At a Glance
Rheumatic heart disease most often affects the mitral valve and can cause narrowing, leaking, or both. Heart ultrasounds classify disease from mild to severe, helping doctors decide on penicillin prevention, closer monitoring, or a valve procedure.
Rheumatic heart disease (RHD) is a progressive condition, but its path is not set in stone. By understanding which valves are affected and what “stage” your disease is in, you and your care team can make informed decisions to protect your heart for the long term [1][2].
Which Valves are Involved?
The heart has four valves that act as one-way doors to keep blood moving in the right direction. RHD can affect any of them, but it follows a very typical pattern [3]:
- The Mitral Valve: This is the most commonly affected valve by RHD [3]. It is frequently involved, either alone or alongside other valves [4].
- The Aortic Valve: This is the second most common valve involved [3]. It is frequently affected at the same time as the mitral valve, a condition known as multivalve disease [5].
- The Tricuspid Valve: Damage here is less common and usually happens after the mitral and aortic valves have already been significantly affected [5][6].
- The Pulmonary Valve: This valve is very rarely affected by RHD [5].
Tightness vs. Leaking
When RHD damages a valve, it usually causes one of two problems (or a mix of both) [7]:
- Stenosis (The Valve is Too Tight): The valve leaflets (flaps) become thick and scarred, sometimes even sticking together at the edges (commissural fusion) [7]. This makes the opening narrow, so the heart has to work much harder to push blood through [8].
- Regurgitation (The Valve is Leaky): The damage prevents the valve from closing tightly [7]. Blood flows backward into the previous chamber of the heart, causing the heart to stretch and enlarge over time to handle the extra volume [9].
Understanding the Stages of RHD
Doctors use a staging system to describe how advanced the disease is and to guide treatment [1]. These stages are determined by an echocardiogram (heart ultrasound) [7].
- Mild Disease: Often found during screening without symptoms [2]. Regular penicillin injections are vital if indicated by your doctor to prevent recurrent rheumatic fever [10].
- Moderate Disease: The valve damage is clear but not yet severe [11]. Treatment includes continued prophylaxis and more frequent monitoring [7].
- Asymptomatic Severe Disease: The valve damage is severe, but you still feel fine [11]. This is a critical window where doctors watch closely to decide the best time for a procedure before permanent damage occurs [12].
- Symptomatic Severe Disease: You have severe valve damage and are experiencing symptoms [11]. At this stage, a procedure like a valvuloplasty (using a balloon to open a tight valve) or valve surgery (repair or replacement) is often evaluated [13][14].
Can the Damage Be Reversed?
One of the most encouraging findings in recent research is that early RHD is not always permanent [15]. Specifically, one observational study found that nearly 52% of children with early echocardiographic signs of RHD saw their echo category improve over five years [16]. However, in some cohorts, about 16% saw their disease get worse over time [17].
This highlights why early diagnosis and strictly following your treatment plan are so powerful [10][18]. Although advanced scarring usually cannot be reversed, it can often be managed effectively to prevent further complications [13].
Common questions in this guide
Which heart valves are usually damaged by rheumatic heart disease?
What is the difference between valve stenosis and regurgitation in RHD?
How does an echocardiogram show the stage of rheumatic heart disease?
Can early rheumatic heart disease get better?
When might a person with RHD need a valve procedure?
Why are regular penicillin injections important in RHD?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Which of my valves are affected, and is the problem primarily stenosis (tightness), regurgitation (leaking), or both?
- 2.Does my current echocardiogram put me in a mild, moderate, or severe stage, and what does that mean for my next steps?
- 3.Since I have more than one valve involved, how does 'multivalve disease' change my monitoring or treatment plan?
- 4.Based on my age and current valve morphology, what is the likelihood that my 'borderline' or 'mild' disease could regress or stabilize with my current penicillin schedule?
- 5.What specific measurements, like my mitral valve area or left ventricular size, are you watching most closely to decide if I need surgery in the future?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
References
References (18)
- 1
2023 World Heart Federation guidelines for the echocardiographic diagnosis of rheumatic heart disease.
Rwebembera J, Marangou J, Mwita JC, et al.
Nature reviews. Cardiology 2024; (21(4)):250-263 doi:10.1038/s41569-023-00940-9.
PMID: 37914787 - 2
Intramuscular versus enteral penicillin prophylaxis to prevent progression of rheumatic heart disease: Study protocol for a noninferiority randomized trial (the GOALIE trial).
Rwebembera J, Ndagire E, Carvalho N, et al.
American heart journal 2024; (275()):74-85 doi:10.1016/j.ahj.2024.05.012.
PMID: 38797460 - 3
Coronary artery disease in patients with rheumatic valvular heart disease- An analysis from eastern India.
Karak A, Deb N, Khanra D, et al.
Indian heart journal 2024; (76(1)):48-50 doi:10.1016/j.ihj.2023.11.268.
PMID: 38043642 - 4
Prevalence of rheumatic heart disease among school children in Ethiopia: A multisite echocardiography-based screening.
Yadeta D, Hailu A, Haileamlak A, et al.
International journal of cardiology 2016; (221()):260-3.
PMID: 27404686 - 5
Clinical outcome of patients with rheumatic tricuspid valve disease: matched cohort study.
Jordão IM, Matos AHS, Prates AB, et al.
The international journal of cardiovascular imaging 2024; (40(9)):1911-1918 doi:10.1007/s10554-024-03180-1.
PMID: 38985216 - 6
Impact of Tricuspid Repair on Surgical Death in Patients Undergoing Mitral Valve Surgery Due to Rheumatic Disease.
Santana GP, Vieira de Melo RM, Viana TT, et al.
Structural heart : the journal of the Heart Team 2024; (8(4)):100298 doi:10.1016/j.shj.2024.100298.
PMID: 39100582 - 7
Recommendations for the Use of Echocardiography in the Evaluation of Rheumatic Heart Disease: A Report from the American Society of Echocardiography.
Pandian NG, Kim JK, Arias-Godinez JA, et al.
Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography 2023; (36(1)):3-28 doi:10.1016/j.echo.2022.10.009.
PMID: 36428195 - 8
Assessment of Subvalvular Apparatus in Patients with Rheumatic Mitral Stenosis: Comparison between 2D and 3D Echocardiography.
Shakil SS, Ahmed CM, Khaled FI, et al.
Mymensingh medical journal : MMJ 2017; (26(4)):716-720.
PMID: 29208857 - 9
Pregnancy Outcomes in Women With Rheumatic Mitral Valve Disease: Results From the Registry of Pregnancy and Cardiac Disease.
van Hagen IM, Thorne SA, Taha N, et al.
Circulation 2018; (137(8)):806-816 doi:10.1161/CIRCULATIONAHA.117.032561.
PMID: 29459466 - 10
Secondary Antibiotic Prophylaxis for Latent Rheumatic Heart Disease.
Beaton A, Okello E, Rwebembera J, et al.
The New England journal of medicine 2022; (386(3)):230-240 doi:10.1056/NEJMoa2102074.
PMID: 34767321 - 11
Profile of adult patients presenting for rheumatic mitral valve surgery at a tertiary academic hospital.
Mokitimi N, van der Donck K, Moutlana H, Chakane PM
Cardiovascular journal of Africa 2021; (32(5)):261-266 doi:10.5830/CVJA-2021-024.
PMID: 34292292 - 12
Echocardiography Assessment of Rheumatic Heart Disease: Implications for Percutaneous Balloon Mitral Valvuloplasty.
Mohamed Ali A, Packer EJS, Omdal TR, et al.
Current problems in cardiology 2023; (48(12)):102021 doi:10.1016/j.cpcardiol.2023.102021.
PMID: 37544629 - 13
Contemporary Diagnosis and Management of Rheumatic Heart Disease: Implications for Closing the Gap: A Scientific Statement From the American Heart Association.
Kumar RK, Antunes MJ, Beaton A, et al.
Circulation 2020; (142(20)):e337-e357 doi:10.1161/CIR.0000000000000921.
PMID: 33073615 - 14
Rheumatic Mitral Valve Stenosis: Diagnosis and Treatment Options.
Wunderlich NC, Dalvi B, Ho SY, et al.
Current cardiology reports 2019; (21(3)):14 doi:10.1007/s11886-019-1099-7.
PMID: 30815750 - 15
Mid-term outcome of children with latent rheumatic heart disease in eastern Nepal.
Shrestha NR, Bruelisauer D, Uranw S, et al.
Open heart 2021; (8(1)) doi:10.1136/openhrt-2021-001605.
PMID: 33820851 - 16
The natural history of latent rheumatic heart disease in a 5 year follow-up study: a prospective observational study.
Zühlke L, Engel ME, Lemmer CE, et al.
BMC cardiovascular disorders 2016; (16()):46 doi:10.1186/s12872-016-0225-3.
PMID: 26892774 - 17
Community-based prevalence of rheumatic heart disease in rural Ethiopia: Five-year follow-up.
Gemechu T, Parry EHO, Yacoub MH, et al.
PLoS neglected tropical diseases 2021; (15(10)):e0009830 doi:10.1371/journal.pntd.0009830.
PMID: 34644305 - 18
Long-term antibiotic prophylaxis for prevention of rheumatic fever recurrence and progression to rheumatic heart disease.
Bray JJ, Thompson S, Seitler S, et al.
The Cochrane database of systematic reviews 2024; (9()):CD015779 doi:10.1002/14651858.CD015779.
PMID: 39312290
This page explains how rheumatic heart disease affects heart valves and how disease stages are assessed for informational purposes only; it does not constitute medical advice. Your healthcare team should interpret your echocardiogram and recommend monitoring or treatment for your specific situation.
Get notified when new evidence is published on rheumatic heart disease.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.